599 related articles for article (PubMed ID: 33081348)
1. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
Ejaz HW; Wang W; Lang M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
[TBL] [Abstract][Full Text] [Related]
2. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
3. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
[TBL] [Abstract][Full Text] [Related]
4. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
5. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
6. The impact of chelating compounds on Cu
Mazur T; Malik M; Bieńko DC
J Inorg Biochem; 2024 Aug; 257():112601. PubMed ID: 38744143
[TBL] [Abstract][Full Text] [Related]
7. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
8. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
9. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
[TBL] [Abstract][Full Text] [Related]
10. Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ
Sun L; Sharma AK; Han BH; Mirica LM
ACS Chem Neurosci; 2020 Sep; 11(17):2741-2752. PubMed ID: 32786307
[TBL] [Abstract][Full Text] [Related]
11. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.
Wang D; Zhang Q; Hu X; Wang W; Zhu X; Yuan Z
Acta Biomater; 2018 Jan; 65():327-338. PubMed ID: 29111371
[TBL] [Abstract][Full Text] [Related]
13. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
[TBL] [Abstract][Full Text] [Related]
14. Copper and Alzheimer's Disease.
Mathys ZK; White AR
Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
[TBL] [Abstract][Full Text] [Related]
15. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
16. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease.
Aaseth J; Skalny AV; Roos PM; Alexander J; Aschner M; Tinkov AA
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502369
[TBL] [Abstract][Full Text] [Related]
17. Metals in Alzheimer's disease: a systemic perspective.
Squitti R
Front Biosci (Landmark Ed); 2012 Jan; 17(2):451-72. PubMed ID: 22201755
[TBL] [Abstract][Full Text] [Related]
18. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.
Miller LM; Wang Q; Telivala TP; Smith RJ; Lanzirotti A; Miklossy J
J Struct Biol; 2006 Jul; 155(1):30-7. PubMed ID: 16325427
[TBL] [Abstract][Full Text] [Related]
19. Novel drug targets based on metallobiology of Alzheimer's disease.
Bandyopadhyay S; Huang X; Lahiri DK; Rogers JT
Expert Opin Ther Targets; 2010 Nov; 14(11):1177-97. PubMed ID: 20942746
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and the amyloid beta peptide in Alzheimer's disease.
Cheignon C; Tomas M; Bonnefont-Rousselot D; Faller P; Hureau C; Collin F
Redox Biol; 2018 Apr; 14():450-464. PubMed ID: 29080524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]